Redeye has updated its estimates and valuation following Physitrack’s Q4 2025 report. While quarterly growth stalled, the Group's structural transformation into a "leaner, meaner" SaaS business is largely complete. We expect the Lifecare division—now representing c85% of Group-reported revenue—to remain the primary profit engine in the near term as the Wellness division enters a rebuilding phase after significant restructuring.
LÄS MER
